CTSG suppresses breast cancer progression by inhibiting the EGFR/ERK signaling pathway and enhancing CD8⁺ T cell activation

Clinical Breast Cancer · Published 2026-07-01 · DOI 10.1016/j.clbc.2026.07.027

Authors (4)

Yue Pan, Chenhui Zheng, Danni Zheng, Yin Pan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pan, Y., Zheng, C., Zheng, D., et al. (2026). CTSG suppresses breast cancer progression by inhibiting the EGFR/ERK signaling pathway and enhancing CD8⁺ T cell activation. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.07.027

Related articles

• Impact of Radiation Therapy on Serum Humanin and MOTS-c Levels inPatients with Lung or Breast Cancer · Current Radiopharmaceuticals · 2024 · Cites or is cited by this article
• Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical Insights · Clinical Medicine Insights: Oncology · 2025 · Cites or is cited by this article
• Evaluating the Efficacy of Neoadjuvant Endocrine Therapy in HER2-Low Versus HER2-Negative Breast Cancer · Clinical Breast Cancer · 2026 · Same journal
• Global Burdens and Trends of Breast Cancer Attributable to Dietary and Metabolic Risks: A 30-Year Analysis With Projections to 2050, Including Males and Females · Clinical Breast Cancer · 2026 · Same journal
• Effect of Treatment Sequencing in Older Adults With Early Breast Cancer. Insights From a Retrospective Single-Institution Cohort · Clinical Breast Cancer · 2026 · Same journal
• Patients With Luminal Breast Carcinoma: The State of the Field in Proteomic and Proteogenomic Molecular Subtyping · Clinical Breast Cancer · 2026 · Same journal
• Methodological Concerns Regarding the Assessment of Breast Cancer Risk Following Gender-Affirming Care · Clinical Breast Cancer · 2026 · Same journal
• Prevalence and Prognostic Implications of Circulating Tumor Cells Among Patients Undergoing Neoadjuvant Chemotherapy for Early-Stage Breast Cancer · Clinical Breast Cancer · 2026 · Same journal
• Association of Regional Anesthesia With Reduced Post-discharge Opioid Prescriptions Following Immediate Autologous Breast Reconstruction: An ACS-NSQIP Analysis · Clinical Breast Cancer · 2026 · Same journal
• Evaluation of Absorbable Hemostatic Powder on Post-operative Outcomes in Patients Undergoing Mastectomy · Clinical Breast Cancer · 2026 · Same journal